Barclays PLC
22 February 2006
22 February 2006
Notification of directors' interests: Companies Act 1985 s.329
On 21 February 2006 the following ordinary shares in Barclays PLC were purchased
on behalf of the following non-executive directors of Barclays PLC at a price of
644.00p per share. As disclosed in the Barclays Annual Report, these purchases
arise from the policy of using part of each director's fee to purchase shares in
Barclays PLC on the directors' behalf which, together with reinvested dividends,
are retained for the director until they leave the Board.
DIRECTOR BARCLAYS PLC TOTAL TOTAL
SHARES BENEFICIAL NON-BENEFICIAL
PURCHASED INTEREST INTEREST
FOLLOWING THIS FOLLOWING THIS
NOTIFICATION NOTIFICATION
Sir David Arculus 1,084 20,854 -
Sir Richard Broadbent 946 7,014 -
Leigh Clifford 864 4,324 -
Dr Danie Cronje 669 2,669 -
Professor Dame Sandra Dawson 983 8,805 -
Sir Andrew Likierman 926 4,554 -
Sir Nigel Rudd 1,083 17,871 -
Stephen Russell 1,060 17,281 -
Robert Steel 811 101,132 -
John Sunderland 882 9,190 -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.